ID   YBOX1_RAT               Reviewed;         322 AA.
AC   P62961; P22568; P27817; P43482; Q4KMA4;
DT   31-AUG-2004, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   02-OCT-2024, entry version 155.
DE   RecName: Full=Y-box-binding protein 1 {ECO:0000303|PubMed:1967130};
DE            Short=YB-1 {ECO:0000303|PubMed:1967130};
DE   AltName: Full=Enhancer factor I subunit A {ECO:0000303|PubMed:1967130};
DE            Short=EFI-A {ECO:0000303|PubMed:1967130};
DE   AltName: Full=Nuclease-sensitive element-binding protein 1;
DE   AltName: Full=Y-box transcription factor;
GN   Name=Ybx1 {ECO:0000312|RGD:61843};
GN   Synonyms=Yb1 {ECO:0000303|PubMed:1967130};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Liver;
RX   PubMed=1967130; DOI=10.1016/s0021-9258(18)45682-7;
RA   Ozer J., Faber M., Chalkley R., Sealy L.;
RT   "Isolation and characterization of a cDNA clone for the CCAAT transcription
RT   factor EFIA reveals a novel structural motif.";
RL   J. Biol. Chem. 265:22143-22152(1990).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Petty K.J., Bartalena L., Nikodem V.M.;
RL   Submitted (JUN-1991) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Ogawa H., Date T., Nishizawa M., Pitot H.C., Fujioka M.;
RL   Submitted (OCT-1992) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Heart, and Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: DNA- and RNA-binding protein involved in various processes,
CC       such as translational repression, RNA stabilization, mRNA splicing, DNA
CC       repair and transcription regulation. Predominantly acts as a RNA-
CC       binding protein: binds preferentially to the 5'-[CU]CUGCG-3' RNA motif
CC       and specifically recognizes mRNA transcripts modified by C5-
CC       methylcytosine (m5C). Promotes mRNA stabilization: acts by binding to
CC       m5C-containing mRNAs and recruiting the mRNA stability maintainer
CC       ELAVL1, thereby preventing mRNA decay. Component of the CRD-mediated
CC       complex that promotes MYC mRNA stability (By similarity). Contributes
CC       to the regulation of translation by modulating the interaction between
CC       the mRNA and eukaryotic initiation factors (By similarity). Plays a key
CC       role in RNA composition of extracellular exosomes by defining the
CC       sorting of small non-coding RNAs, such as tRNAs, Y RNAs, Vault RNAs and
CC       miRNAs. Probably sorts RNAs in exosomes by recognizing and binding C5-
CC       methylcytosine (m5C)-containing RNAs. Acts as a key effector of
CC       epidermal progenitors by preventing epidermal progenitor senescence:
CC       acts by regulating the translation of a senescence-associated subset of
CC       cytokine mRNAs, possibly by binding to m5C-containing mRNAs. Also
CC       involved in pre-mRNA alternative splicing regulation: binds to splice
CC       sites in pre-mRNA and regulates splice site selection. Binds to TSC22D1
CC       transcripts, thereby inhibiting their translation and negatively
CC       regulating TGF-beta-mediated transcription of COL1A2 (By similarity).
CC       Also able to bind DNA: regulates transcription of the multidrug
CC       resistance gene MDR1 is enhanced in presence of the APEX1 acetylated
CC       form at 'Lys-6' and 'Lys-7'. Binds to promoters that contain a Y-box
CC       (5'-CTGATTGGCCAA-3'), such as MDR1 and HLA class II genes. Promotes
CC       separation of DNA strands that contain mismatches or are modified by
CC       cisplatin. Has endonucleolytic activity and can introduce nicks or
CC       breaks into double-stranded DNA, suggesting a role in DNA repair. The
CC       secreted form acts as an extracellular mitogen and stimulates cell
CC       migration and proliferation (By similarity).
CC       {ECO:0000250|UniProtKB:P62960, ECO:0000250|UniProtKB:P67809,
CC       ECO:0000250|UniProtKB:Q28618}.
CC   -!- SUBUNIT: Homodimer in the presence of ATP. Component of the coding
CC       region determinant (CRD)-mediated complex, composed of DHX9, HNRNPU,
CC       IGF2BP1, SYNCRIP and YBX1. Identified in a IGF2BP1-dependent mRNP
CC       granule complex containing untranslated mRNAs. Component of the U11/U12
CC       snRNPs that are part of the U12-type spliceosome (By similarity).
CC       Identified in a histone pre-mRNA complex, at least composed of ERI1,
CC       LSM11, SLBP, SNRPB, SYNCRIP and YBX1 (By similarity). Interacts with
CC       IGF2BP1 and RBBP6. Component of cytoplasmic messenger ribonucleoprotein
CC       particles (mRNPs). Interacts with AKT1, MBNL1, SFRS9, SFRS12,
CC       ALYREF/THOC4, MSH2, XRCC5, WRN and NCL. Interacts (via C-terminus) with
CC       APEX1 (via N-terminus); the interaction is increased with APEX1
CC       acetylated at 'Lys-6' and 'Lys-7'. Interacts with AGO1 and AGO2.
CC       Interacts with ANKRD2. Interacts with DERA (By similarity). Interacts
CC       with FMR1; this interaction occurs in association with polyribosome.
CC       Interacts with ZBTB7B (By similarity). Interacts with HDGF. Interacts
CC       with ELAVL1; leading to ELAVL1 recruitment on C5-methylcytosine (m5C)-
CC       containing mRNAs and subsequent mRNA stability (By similarity).
CC       Interacts with PURB (By similarity). {ECO:0000250|UniProtKB:P62960,
CC       ECO:0000250|UniProtKB:P67809}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:P67809}. Nucleus
CC       {ECO:0000250|UniProtKB:P67809}. Cytoplasmic granule
CC       {ECO:0000250|UniProtKB:P67809}. Secreted
CC       {ECO:0000250|UniProtKB:P67809}. Secreted, extracellular exosome
CC       {ECO:0000250|UniProtKB:P67809}. Cytoplasm, P-body
CC       {ECO:0000250|UniProtKB:P62960}. Note=Predominantly cytoplasmic in
CC       proliferating cells. Cytotoxic stress and DNA damage enhance
CC       translocation to the nucleus. Localized in cytoplasmic mRNP granules
CC       containing untranslated mRNAs. Shuttles between nucleus and cytoplasm.
CC       Localized with DDX1, MBNL1 and TIAL1 in stress granules upon stress.
CC       Secreted by mesangial and monocytic cells after inflammatory
CC       challenges. {ECO:0000250|UniProtKB:P67809}.
CC   -!- DOMAIN: In the CSD domain, Trp-63 specifically recognizes C5-
CC       methylcytosine (m5C) modification through its indole ring.
CC       {ECO:0000250|UniProtKB:P67809}.
CC   -!- PTM: Ubiquitinated by RBBP6; leading to a decrease of YBX1
CC       transactivational ability. {ECO:0000250|UniProtKB:P67809}.
CC   -!- PTM: Phosphorylated; increased by TGFB1 treatment (By similarity).
CC       Phosphorylation by PKB/AKT1 reduces interaction with cytoplasmic mRNA
CC       (By similarity). In the absence of phosphorylation the protein is
CC       retained in the cytoplasm (By similarity).
CC       {ECO:0000250|UniProtKB:P62960, ECO:0000250|UniProtKB:P67809,
CC       ECO:0000250|UniProtKB:Q28618}.
CC   -!- PTM: Cleaved by a 20S proteasomal protease in response to agents that
CC       damage DNA. Cleavage takes place in the absence of ubiquitination and
CC       ATP. The resulting N-terminal fragment accumulates in the nucleus (By
CC       similarity). {ECO:0000250|UniProtKB:Q28618}.
CC   -!- SIMILARITY: Belongs to the YBX1 family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M57299; AAA41108.1; -; mRNA.
DR   EMBL; M69138; AAA40906.1; -; mRNA.
DR   EMBL; D13309; BAA02569.1; -; mRNA.
DR   EMBL; BC072486; AAH72486.1; -; mRNA.
DR   EMBL; BC098672; AAH98672.1; -; mRNA.
DR   PIR; A23677; A23677.
DR   RefSeq; NP_113751.3; NM_031563.3.
DR   AlphaFoldDB; P62961; -.
DR   BMRB; P62961; -.
DR   SMR; P62961; -.
DR   BioGRID; 271846; 7.
DR   IntAct; P62961; 9.
DR   MINT; P62961; -.
DR   STRING; 10116.ENSRNOP00000015875; -.
DR   iPTMnet; P62961; -.
DR   PhosphoSitePlus; P62961; -.
DR   jPOST; P62961; -.
DR   PaxDb; 10116-ENSRNOP00000055494; -.
DR   GeneID; 500538; -.
DR   KEGG; rno:500538; -.
DR   UCSC; RGD:61843; rat.
DR   AGR; RGD:61843; -.
DR   CTD; 4904; -.
DR   RGD; 61843; Ybx1.
DR   eggNOG; KOG3070; Eukaryota.
DR   InParanoid; P62961; -.
DR   OrthoDB; 5487692at2759; -.
DR   PhylomeDB; P62961; -.
DR   Reactome; R-RNO-72163; mRNA Splicing - Major Pathway.
DR   Reactome; R-RNO-72165; mRNA Splicing - Minor Pathway.
DR   Reactome; R-RNO-72203; Processing of Capped Intron-Containing Pre-mRNA.
DR   Reactome; R-RNO-877300; Interferon gamma signaling.
DR   Reactome; R-RNO-9017802; Noncanonical activation of NOTCH3.
DR   PRO; PR:P62961; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0070937; C:CRD-mediated mRNA stability complex; ISO:RGD.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0010494; C:cytoplasmic stress granule; ISS:UniProtKB.
DR   GO; GO:0030425; C:dendrite; IDA:RGD.
DR   GO; GO:0070062; C:extracellular exosome; ISS:UniProtKB.
DR   GO; GO:0071204; C:histone pre-mRNA 3'end processing complex; ISS:UniProtKB.
DR   GO; GO:0043025; C:neuronal cell body; IDA:RGD.
DR   GO; GO:0005634; C:nucleus; ISO:RGD.
DR   GO; GO:0000932; C:P-body; ISO:RGD.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IDA:RGD.
DR   GO; GO:0032991; C:protein-containing complex; IDA:RGD.
DR   GO; GO:1990904; C:ribonucleoprotein complex; ISS:UniProtKB.
DR   GO; GO:0045202; C:synapse; ISO:RGD.
DR   GO; GO:0005689; C:U12-type spliceosomal complex; ISO:RGD.
DR   GO; GO:0062153; F:C5-methylcytidine-containing RNA reader activity; ISS:UniProtKB.
DR   GO; GO:0003682; F:chromatin binding; ISO:RGD.
DR   GO; GO:0051020; F:GTPase binding; ISO:RGD.
DR   GO; GO:0035198; F:miRNA binding; ISS:UniProtKB.
DR   GO; GO:0003729; F:mRNA binding; IPI:RGD.
DR   GO; GO:0003676; F:nucleic acid binding; IBA:GO_Central.
DR   GO; GO:0002039; F:p53 binding; IMP:RGD.
DR   GO; GO:0003723; F:RNA binding; IDA:RGD.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IDA:RGD.
DR   GO; GO:1990837; F:sequence-specific double-stranded DNA binding; ISO:RGD.
DR   GO; GO:0003697; F:single-stranded DNA binding; IDA:RGD.
DR   GO; GO:0098761; P:cellular response to interleukin-7; ISO:RGD.
DR   GO; GO:0070934; P:CRD-mediated mRNA stabilization; ISS:UniProtKB.
DR   GO; GO:0048598; P:embryonic morphogenesis; ISS:UniProtKB.
DR   GO; GO:0008544; P:epidermis development; ISS:UniProtKB.
DR   GO; GO:0001701; P:in utero embryonic development; ISO:RGD.
DR   GO; GO:1990428; P:miRNA transport; ISS:UniProtKB.
DR   GO; GO:0006397; P:mRNA processing; IEA:UniProtKB-KW.
DR   GO; GO:0048255; P:mRNA stabilization; ISS:UniProtKB.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IDA:RGD.
DR   GO; GO:2000773; P:negative regulation of cellular senescence; ISS:UniProtKB.
DR   GO; GO:0046627; P:negative regulation of insulin receptor signaling pathway; IMP:RGD.
DR   GO; GO:1900152; P:negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; ISO:RGD.
DR   GO; GO:0051154; P:negative regulation of striated muscle cell differentiation; ISO:RGD.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IDA:RGD.
DR   GO; GO:0017148; P:negative regulation of translation; ISS:UniProtKB.
DR   GO; GO:0051781; P:positive regulation of cell division; IEA:UniProtKB-KW.
DR   GO; GO:0008284; P:positive regulation of cell population proliferation; IMP:RGD.
DR   GO; GO:2000767; P:positive regulation of cytoplasmic translation; ISO:RGD.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IMP:RGD.
DR   GO; GO:1903608; P:protein localization to cytoplasmic stress granule; ISO:RGD.
DR   GO; GO:0006355; P:regulation of DNA-templated transcription; ISO:RGD.
DR   GO; GO:0010468; P:regulation of gene expression; IBA:GO_Central.
DR   GO; GO:0008380; P:RNA splicing; IEA:UniProtKB-KW.
DR   GO; GO:0050658; P:RNA transport; ISS:UniProtKB.
DR   GO; GO:0051031; P:tRNA transport; ISS:UniProtKB.
DR   CDD; cd04458; CSP_CDS; 1.
DR   Gene3D; 2.40.50.140; Nucleic acid-binding proteins; 1.
DR   InterPro; IPR050181; Cold_shock_domain.
DR   InterPro; IPR011129; CSD.
DR   InterPro; IPR019844; CSD_CS.
DR   InterPro; IPR002059; CSP_DNA-bd.
DR   InterPro; IPR012340; NA-bd_OB-fold.
DR   PANTHER; PTHR11544; COLD SHOCK DOMAIN CONTAINING PROTEINS; 1.
DR   PANTHER; PTHR11544:SF68; Y-BOX-BINDING PROTEIN 1; 1.
DR   Pfam; PF00313; CSD; 1.
DR   PRINTS; PR00050; COLDSHOCK.
DR   SMART; SM00357; CSP; 1.
DR   SUPFAM; SSF50249; Nucleic acid-binding proteins; 1.
DR   PROSITE; PS00352; CSD_1; 1.
DR   PROSITE; PS51857; CSD_2; 1.
PE   2: Evidence at transcript level;
KW   Acetylation; Activator; Cytoplasm; DNA-binding; Isopeptide bond; Mitogen;
KW   mRNA processing; mRNA splicing; Nucleus; Phosphoprotein;
KW   Reference proteome; Repressor; RNA-binding; Secreted; Transcription;
KW   Transcription regulation; Ubl conjugation.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000250|UniProtKB:P67809"
FT   CHAIN           2..322
FT                   /note="Y-box-binding protein 1"
FT                   /id="PRO_0000100221"
FT   DOMAIN          59..123
FT                   /note="CSD"
FT   REGION          1..47
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          14..69
FT                   /note="Interaction with ss-DNA"
FT                   /evidence="ECO:0000250|UniProtKB:P67809"
FT   REGION          63..68
FT                   /note="C5-methylcytosine binding"
FT                   /evidence="ECO:0000250|UniProtKB:P67809"
FT   REGION          118..322
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        154..179
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        248..267
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        286..304
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   SITE            63
FT                   /note="Important for C5-methylcytosine-recognition"
FT                   /evidence="ECO:0000250|UniProtKB:P67809"
FT   SITE            217..218
FT                   /note="Cleavage; by 20S proteasomal protease"
FT                   /evidence="ECO:0000250|UniProtKB:Q28618"
FT   MOD_RES         2
FT                   /note="N-acetylserine"
FT                   /evidence="ECO:0000250|UniProtKB:P67809"
FT   MOD_RES         100
FT                   /note="Phosphoserine; by PKB/AKT1"
FT                   /evidence="ECO:0000250|UniProtKB:P67809"
FT   MOD_RES         160
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:P67809"
FT   MOD_RES         163
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P67809"
FT   MOD_RES         165
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P67809"
FT   MOD_RES         172
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P67809"
FT   MOD_RES         174
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P67809"
FT   MOD_RES         299
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P67809"
FT   MOD_RES         302
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P67809"
FT   MOD_RES         312
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P67809"
FT   CROSSLNK        24
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P67809"
FT   CROSSLNK        135
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000250|UniProtKB:P67809"
FT   CONFLICT        5
FT                   /note="A -> P (in Ref. 2; AAA40906)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        306
FT                   /note="P -> S (in Ref. 1; AAA41108)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   322 AA;  35730 MW;  C6667CF7CA10D45D CRC64;
     MSSEAETQQP PAAPAAALSA ADTKPGSTGS GAGSGGPGGL TSAAPAGGDK KVIATKVLGT
     VKWFNVRNGY GFINRNDTKE DVFVHQTAIK KNNPRKYLRS VGDGETVEFD VVEGEKGAEA
     ANVTGPGGVP VQGSKYAADR NHYRRYPRRR GPPRNYQQNY QNSESGEKNE GSESAPEGQA
     QQRRPYRRRR FPPYYMRRPY ARRPQYSNPP VQGEVMEGAD NQGAGEQGRP VRQNMYRGYR
     PRFRRGPPRQ RQPREDGNEE DKENQGDETQ GQQPPQRRYR RNFNYRRRRP ENPKPQDGKE
     TKAADPPAEN SSAPEAEQGG AE
//
